PF-06282999   Click here for help

GtoPdb Ligand ID: 10053

Synonyms: compound 8 [PMID: 26509551] | PF06282999
Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: PF-06282999 is a thiouracil-based, irreversible mechanism-based, investigational myeloperoxidase (MPO) inhibitor [2] that was advanced as a clinical candidate, primarily as a novel treatment for cardiovascular diseases [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 122.2
Molecular weight 325.03
XLogP 2.53
No. Lipinski's rules broken 0
Click here for help
Canonical SMILES COc1ccc(cc1c1cc(=O)[nH]c(=S)n1CC(=O)N)Cl
Isomeric SMILES COc1ccc(cc1c1cc(=O)[nH]c(=S)n1CC(=O)N)Cl
InChI InChI=1S/C13H12ClN3O3S/c1-20-10-3-2-7(14)4-8(10)9-5-12(19)16-13(21)17(9)6-11(15)18/h2-5H,6H2,1H3,(H2,15,18)(H,16,19,21)
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
myeloperoxidase Primary target of this compound Hs Inhibitor Inhibition 6.5 pKi - 2
pKi 6.5 (Ki 3.16x10-7 M) [2]
Description: Inhibition of the peroxidase activity of MPO isolated from human polynuclear leukocytes.